Helsinki - Delayed Quote EUR

Orion Oyj (ORNBV.HE)

35.85 +0.46 (+1.30%)
At close: April 26 at 6:29 PM GMT+3
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,220,100.00
1,189,600.00
1,340,700.00
1,041,000.00
1,078,100.00
Cost of Revenue
548,000.00
531,900.00
489,000.00
447,500.00
434,400.00
Gross Profit
672,100.00
657,700.00
851,700.00
593,500.00
643,700.00
Operating Expense
406,400.00
392,500.00
415,400.00
355,800.00
367,300.00
Operating Income
265,700.00
265,200.00
436,300.00
237,700.00
276,400.00
Net Non Operating Interest Income Expense
-3,600.00
-2,800.00
-800.00
-1,200.00
-1,000.00
Pretax Income
271,700.00
271,900.00
440,300.00
242,300.00
278,300.00
Tax Provision
55,000.00
55,100.00
90,800.00
48,500.00
58,400.00
Net Income Common Stockholders
216,800.00
216,800.00
349,500.00
193,800.00
219,900.00
Diluted NI Available to Com Stockholders
216,800.00
216,800.00
349,500.00
193,800.00
219,900.00
Basic EPS
1.54
1.54
2.49
1.38
1.56
Diluted EPS
1.54
1.54
2.49
1.38
1.56
Basic Average Shares
140,364.02
140,326.68
140,501.28
140,546.56
140,506.97
Diluted Average Shares
140,404.76
140,361.04
140,589.74
140,563.90
140,506.97
Total Operating Income as Reported
--
274,900.00
439,600.00
243,300.00
280,100.00
Total Expenses
954,400.00
924,400.00
904,400.00
803,300.00
801,700.00
Net Income from Continuing & Discontinued Operation
216,800.00
216,800.00
349,500.00
193,800.00
219,900.00
Normalized Income
210,499.19
210,503.70
349,182.40
190,600.00
219,662.95
Interest Income
--
2,900.00
1,000.00
100.00
200.00
Interest Expense
--
5,200.00
1,500.00
1,000.00
900.00
Net Interest Income
-3,600.00
-2,800.00
-800.00
-1,200.00
-1,000.00
EBIT
277,600.00
277,100.00
441,800.00
243,300.00
279,200.00
EBITDA
277,600.00
328,600.00
489,300.00
289,100.00
335,700.00
Reconciled Cost of Revenue
548,000.00
531,900.00
489,000.00
447,500.00
434,400.00
Reconciled Depreciation
--
51,500.00
47,500.00
45,800.00
56,500.00
Net Income from Continuing Operation Net Minority Interest
216,800.00
216,800.00
349,500.00
193,800.00
219,900.00
Total Unusual Items Excluding Goodwill
7,900.00
7,900.00
400.00
4,000.00
300.00
Total Unusual Items
7,900.00
7,900.00
400.00
4,000.00
300.00
Normalized EBITDA
269,700.00
320,700.00
488,900.00
285,100.00
335,400.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
1,599.19
1,603.70
82.40
800.00
62.95
12/31/2020 - 10/7/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AZN.ST AstraZeneca PLC
1,646.00
+0.27%
 
4AB.DE AbbVie Inc.
150.98
-3.02%
 
PFE.DE Pfizer Inc.
23.79
-0.25%
 
REC.MI Recordati Industria Chimica e Farmaceutica S.p.A.
49.10
+0.61%
 
RO.SW Roche Holding AG
240.00
+1.35%
 
BAYN.DE Bayer Aktiengesellschaft
27.40
+1.88%
 
SAN.PA Sanofi
91.23
-0.43%
 
GRFS Grifols, S.A.
6.38
+1.75%
 
ROG.SW Roche Holding AG
221.00
+1.01%
 
AZN.L AstraZeneca PLC
11,988.00
-0.32%